Clinical pharmacokinetics of felodipine. A summary

scientific article

Clinical pharmacokinetics of felodipine. A summary is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P698PubMed publication ID3327676

P2093author name stringEdgar B
Regårdh CG
Lundborg P
P2860cites workCalcium antagonism--a new concept for treating essential hypertensionQ39500045
Antihypertensive effects and pharmacokinetics of felodipine combined with a beta-blocker and a diureticQ43803791
Acute diuretic/natriuretic properties of felodipine in man.Q44826492
Felodipine. A calcium-inhibiting vasodilator in refractory hypertensionQ45058296
Pharmacokinetics and haemodynamics of felodipine in hypertensive patients treated concomitantly with a beta-blockerQ45332519
Metabolism of [14C] felodipine, a new vasodilating drug, in healthy volunteers.Q52614145
Felodipine kinetics in healthy men.Q54117719
Pharmacokinetic and pharmacodynamic studies of felodipine in healthy subjects after various single, oral and intravenous doses.Q54407139
Vascular selectivity of felodipine.Q54457513
Acute haemodynamic effects of felodipine and verapamil in man, singly and with metoprolol.Q54457528
Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects.Q54504191
Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertensionQ68687153
Pharmacokinetics of felodipine and effect on digoxin plasma levels in patients with heart failureQ68687176
Treatment of essential hypertension with felodipine in combination with a diureticQ68877420
Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patientsQ69443400
Pharmacokinetic interactions between felodipine and metoprololQ69785615
Haemodynamic effects of intravenous felodipine in normotensive and hypertensive subjectsQ70087021
Absorption, distribution and elimination of felodipine in manQ70087050
Urinary metabolites of felodipine, a new vasodilator drug, in man, dog, rat and mouseQ70662061
Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in manQ70702521
Pharmacokinetics of nicardipine following oral and intravenous administration in manQ70759563
Felodipine ? A new vasodilator, in addition to ?-receptor blockade in hypertensionQ72570993
Dissolution test for felodipine tablets using chemical oxidation in situ to maintain 'sink conditions'Q79987087
P921main subjectpharmacokineticsQ323936
P304page(s)16-27
P577publication date1987-01-01
P1433published inDrugsQ3040094
P1476titleClinical pharmacokinetics of felodipine. A summary
P478volume34 Suppl 3

Reverse relations

cites work (P2860)
Q34358245A population study of the pharmacokinetics of felodipine
Q51600896Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release (ER) tablets.
Q44754266Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine--and its potential clinical relevance
Q36115910Clinical pharmacokinetics of calcium antagonists. An update
Q47913024Clinical pharmacokinetics of vasodilators. Part I.
Q68687153Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension
Q67773747Comparison of once daily felodipine 10 mg ER and hydrochlorothiazide 25 mg in the treatment of mild to moderate hypertension
Q92661592Delivery of Poorly Soluble Drugs via Mesoporous Silica: Impact of Drug Overloading on Release and Thermal Profiles
Q45905746Effect of felodipine on histamine and adenosine induced bronchoconstriction in patients with asthma
Q45183952Effect of menthol on the pharmacokinetics and pharmacodynamics of felodipine in healthy subjects
Q28325479Felodipine Clinical Pharmacokinetics
Q69665183Felodipine reduces the absorption of theophylline in man
Q39567108Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension
Q35336765Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders
Q33863421Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension
Q40743038Grapefruit juice and drugs. How significant is the interaction?
Q70259509Hemodynamic interactions between diuretics and calcium antagonists in the treatment of hypertensive patients
Q68448575Pharmacokinetics and blood pressure effects of felodipine in elderly hypertensive patients. A comparison with young healthy subjects
Q54311400Pharmacokinetics and hemodynamic and diuretic/natriuretic effects of felodipine administered as an extended-release tablet.
Q43222722Plasma concentration profiles and antihypertensive effect of conventional and extended-release felodipine tablets
Q70612415Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics

Search more.